EDUCATION & TRAINING:
BS, University of Washington, Seattle (2006-2010)
Fulbright Fellow, Amman, Jordan (2010-2011)
MD, University of Washington, Seattle (2013-2017)
Residency, Boston University Medical Center (2017-2020)
Fellowship, University of California San Francisco (2020-2023)
MAS, University of California San Francisco (2021-2023)
Dr. Stovall is an academic rheumatologist and clinical researcher whose research focuses on outcomes in spondyloarthritis. She uses large observational datasets, including electronic health record data, to answer important questions that cannot be answered by clinical trials due to the need for larger numbers of patients followed over longer periods of time. She is currently studying sex differences related to clinically important outcomes among patients with spondyloarthritis. She is a member of the Spondyloarthritis Research and Treatment Network (SPARTAN) and Assessment of SpondyloArthritis international Society (ASAS).
Incidence rate and factors associated with fractures among Medicare beneficiaries with ankylosing spondylitis in the United States. Arthritis Care Res (Hoboken). Published online August 22, 2023. Stovall R, Kersey E, Li J, Baker R, Anastasiou C, Palmowski A, Schmajuk G, Gensler L, Yazdany J. PMID: 37605840.
Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis. Nat Rev Rheumatol. 2022 11; 18(11):657-669. Stovall R, van der Horst-Bruinsma IE, Liu SH, Rusman T, Gensler LS. PMID: 36109666.
Relation of therapies for ankylosing spondylitis and psoriatic arthritis to risk of myocardial infarction: a nested case control study. BMC Rheumatol. 2021 Jul 29; 5(1):36. Stovall R, Peloquin C, Felson D, Neogi T, Dubreuil M. PMID: 34321112; PMCID: PMC8320220.
Relation of NSAIDs, DMARDs, and TNF Inhibitors for Ankylosing Spondylitis and Psoriatic Arthritis to Risk of Total Hip and Knee Arthroplasty. J Rheumatol. 2021 07; 48(7):1007-1013. Stovall R, Peloquin C, Felson D, Neogi T, Dubreuil M. PMID: 33452168.